Page last updated: 2024-10-30

edaravone and Bell Palsy

edaravone has been researched along with Bell Palsy in 1 studies

Bell Palsy: A syndrome characterized by the acute onset of unilateral FACIAL PARALYSIS which progresses over a 2-5 day period. Weakness of the orbicularis oculi muscle and resulting incomplete eye closure may be associated with corneal injury. Pain behind the ear often precedes the onset of paralysis. This condition may be associated with HERPESVIRUS 1, HUMAN infection of the facial nerve. (Adams et al., Principles of Neurology, 6th ed, p1376)

Research Excerpts

ExcerptRelevanceReference
" The incidence of facial palsy was assessed following administration of edaravone immediately after HSV-1 inoculation and daily for 11 days thereafter."3.79Role of nitric oxide in the onset of facial nerve palsy by HSV-1 infection. ( Gyo, K; Hato, N; Kohno, H; Takahashi, H; Yamada, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hato, N1
Kohno, H1
Yamada, H1
Takahashi, H1
Gyo, K1

Other Studies

1 other study available for edaravone and Bell Palsy

ArticleYear
Role of nitric oxide in the onset of facial nerve palsy by HSV-1 infection.
    JAMA otolaryngology-- head & neck surgery, 2013, Volume: 139, Issue:12

    Topics: Animals; Antipyrine; Bell Palsy; Biomarkers; Disease Models, Animal; Edaravone; Facial Nerve; Facial

2013